SIBO Treatment: How to Treat SIBO with Antibiotics, Diet, and Natural Options — and Why "Cure" Is the Wrong Word
SIBO is treated in layers — antibiotics, diet, sometimes herbal antimicrobials or an elemental diet — not "cured" with one product, and every layer is a clinician's call.

Short Answer
If you searched how to cure SIBO, the most useful answer is less dramatic and more honest: SIBO is usually treated in layers, not "cured" with one product, one diet, or one antibiotic course. The realistic goal is to reduce the overgrowth, relieve symptoms, correct nutritional problems if they exist, and make recurrence less likely by addressing the reason bacteria built up in the small intestine in the first place. That reason may be impaired gut motility, anatomy after surgery, strictures or fistulas, certain digestive or systemic diseases, medication effects, or malabsorption. Mayo Clinic describes treatment as dealing with the underlying problem when possible, correcting deficiencies, and eliminating bacterial overgrowth; it also notes that bacteria can return after antibiotics are stopped. (Mayo Clinic)
For many people, the first active layer is a clinician-chosen antibiotic. Rifaximin for SIBO treatment is the best-studied gut-targeted option and is commonly used for hydrogen-dominant SIBO, but methane-dominant cases are different: they are often framed as intestinal methanogen overgrowth, because methane is produced by archaea rather than bacteria, so clinicians may choose a different antibiotic strategy instead of treating it like ordinary hydrogen SIBO. The ACG guideline summarizes diagnostic and treatment options for SIBO, and rifaximin meta-analyses show benefit while also emphasizing that study quality and regimens vary. (ACG Clinical Guideline: SIBO, 2020)
Diet helps, but it is not a stand-alone cure. A low-FODMAP or otherwise targeted dietary approach can lower the fermentable fuel that bacteria turn into gas, which may reduce bloating, discomfort, diarrhea, constipation swings, and food-triggered flares while treatment and reintroduction are underway. Johns Hopkins describes low-FODMAP as part of therapy for IBS, SIBO, and IMO; Cleveland Clinic notes it may help symptom management in SIBO, though evidence outside IBS is more limited. In practice, that means diet is usually a symptom-control and reintroduction tool, not proof that the overgrowth is gone. (Johns Hopkins Medicine)
"Natural ways to treat SIBO" should be held to the same safety standard as prescription care. Some clinicians use herbal antimicrobials — including formulas that may contain oregano oil or berberine-type botanicals — as an alternative or adjunct, and one older study found herbal therapy produced similar breath-test normalization rates to rifaximin in a nonrandomized clinical setting. But that does not mean any supplement stack is safe, interchangeable, or appropriate for you. FDA warns that dietary supplements are not approved for safety and effectiveness before marketing, can interact with medicines, and that "natural" does not automatically mean safe. (Chedid et al., 2014, *Glob Adv Health Med*)
An elemental diet is a different level of intervention: it is a medically supervised liquid nutrition approach sometimes used when antibiotics fail, cannot be tolerated, or are not an option. It can reduce fermentable substrate in the gut, but it is restrictive, difficult to complete, and not something to self-prescribe — especially if you have weight loss, malnutrition risk, diabetes, kidney disease, pregnancy, an eating-disorder history, or complex medications. Reviews describe elemental diet as an alternative for refractory or antibiotic-intolerant SIBO/IMO, not a casual "cleanse." (Vasant et al., review, *PMC*)
Follow-up matters because recurrence is common when the root driver stays in place. In one study of people whose breath tests normalized after rifaximin, SIBO recurrence was reported in 12.6% at 3 months, 27.5% at 6 months, and 43.7% at 9 months. That is why the "after" plan — rechecking symptoms, rebuilding food tolerance, correcting deficiencies, reviewing medications, and sometimes using a clinician-prescribed prokinetic when dysmotility is part of the picture — can matter more than chasing the strongest single course. (Lauritano et al., 2008, *Am J Gastroenterol*)
Welltory does not measure gut bacteria, breath gases, or diagnose or treat SIBO. What it can help you do is track the context around your symptoms — sleep, stress load, HRV-based recovery, and how your body responds through a treatment course and food reintroduction — as a pattern to share with your clinician, not a measure of the overgrowth itself.
SIBO treatment options at a glance
Think of SIBO treatment as layers, not one magic "cure." The first medical layer is usually antibiotics to reduce bacterial overgrowth, while your clinician also looks for the reason bacteria were able to build up in the small intestine in the first place — slow motility, a structural problem, prior surgery, malabsorption, or another driver. Rifaximin is the most studied option, especially for hydrogen-dominant SIBO; methane/IMO patterns may need a different or combination approach because methane is linked to methanogens, not just bacteria. Antibiotics, repeat courses, timing, and which drug fits your breath-test pattern are clinician decisions — not a DIY protocol. (ACG Clinical Guideline: SIBO, 2020)
The next layer is diet, usually used to calm fermentation while treatment is happening or after symptoms flare. A low-FODMAP plan can reduce bloating, gas, and abdominal discomfort because it temporarily lowers the fermentable carbohydrates that gut microbes turn into gas. But it is not meant to be forever and it is not a cure: the point is elimination, then careful reintroduction so you find your personal triggers without shrinking your diet unnecessarily. Working with a GI dietitian matters here, especially if you already have weight loss, food fear, nutrient deficiencies, or a very limited food list. (Cleveland Clinic)
"Natural" options sit in a separate layer. Herbal antimicrobials — such as oregano oil, berberine-containing formulas, or multi-herb protocols — may have real antimicrobial effects, which is exactly why they can also cause side effects, interact with medications, or be wrong for pregnancy, liver disease, kidney disease, anticoagulant use, or complex GI illness. The evidence base is thinner than for antibiotics: one retrospective study found herbal protocols performed similarly to rifaximin on follow-up breath testing, but the authors called for prospective studies. Treat SIBO with herbs only with a clinician who knows your diagnosis, medications, risks, and follow-up plan. (Chedid et al., 2014, *Glob Adv Health Med*)
Elemental diet is a higher-intensity option, not a wellness cleanse. It uses a pre-digested liquid formula that is absorbed high in the small intestine, leaving less for microbes farther down to ferment. That can be useful in severe, refractory, or antibiotic-intolerant cases, but it is nutritionally and psychologically demanding, and some people cannot tolerate it. This should be supervised, especially if you have diabetes, eating-disorder history, significant weight loss, pregnancy, kidney disease, or multiple medical conditions. (Rao & Bhagatwala, 2019, *Clin Transl Gastroenterol*)
The recurrence-prevention layer is motility and root-cause work. If your small intestine is moving slowly, bacteria get more time to sit, ferment, and multiply; this is why prokinetics or promotility strategies may be considered after overgrowth is reduced. Sleep, stress regulation, meal spacing, constipation management, and treating the underlying structural or motility problem are supporting pieces — they help the gut keep results, but they do not replace medical treatment when active overgrowth is driving symptoms. (Grace et al., review, *Aliment Pharmacol Ther*)
Why "cure" is the wrong frame
It makes sense to search for "how to cure SIBO" when your gut feels unpredictable, loud, and hard to trust. But "cure" is usually the wrong promise. SIBO can come back because clearing excess bacteria does not automatically fix the body conditions that let them build up in the small intestine in the first place — especially slowed or disordered gut movement, which normally helps sweep bacteria forward. In one follow-up study, breath-test positivity returned in 43.7% of patients within 9 months after successful antibiotic treatment, which is why clinicians tend to think in terms of clearance, symptom control, and relapse prevention rather than a one-time permanent fix. (Lauritano et al., 2008, *Am J Gastroenterol*)
A more honest frame comes from the closely related IBS literature, which states plainly that «there is currently no known cure for irritable bowel syndrome» while also emphasizing that symptom-focused interventions can meaningfully help (Cheung & Kenway, 2026, *Journal of Nutrition and Metabolism*). For SIBO, the parallel is practical: the goal is not to "sterilize" your gut or chase a guaranteed SIBO cure. The goal is to reduce the overgrowth, calm the symptoms, and address the reason your small intestine became vulnerable — motility problems, anatomy, medications, or another underlying driver your clinician can help look for. That is durable remission thinking, not magic-bullet thinking. Be skeptical of any product or protocol promising a guaranteed SIBO cure.
Antibiotics — the first-line treatment
Antibiotics are usually the first medical layer when SIBO is confirmed and symptoms fit the breath-test pattern. For hydrogen-dominant SIBO, the drug clinicians often reach for is rifaximin: a gut-targeted, minimally absorbed antibiotic that works mainly inside the intestine rather than throughout the whole body. It is also the best-studied antibiotic in SIBO research, although the evidence is still mixed enough that it should be treated as a clinician-directed tool — not a guaranteed reset button. (Rao & Bhagatwala, 2019, *Clin Transl Gastroenterol*)
It sits among the recommended management options in the European consensus, which lists «dietary modifications (e.g. lactose-limiting diet and low FODMAP diet), probiotics, antispasmodics (e.g., otilonium bromide, peppermint oil), rifaximin, secretagogues» (Melchior et al., 2025, *United European Gastroenterology Journal*). The same consensus describes rifaximin as a rifamycin-family antibiotic with minimal systemic absorption, which is why it is often discussed as "gut-targeted."
Methane-dominant overgrowth — now often called intestinal methanogen overgrowth, or IMO — is different. Methane is produced by archaea, not ordinary hydrogen-producing bacteria, so a hydrogen-style plan may not work the same way. In methane-positive patients, clinicians may consider a different antibiotic or a combination approach; studies have evaluated combination therapy for methane-associated constipation and bloating, but this is exactly the kind of decision that depends on your test results, symptoms, medical history, and safety risks. (Pimentel et al., review)
Rifaximin and any other antibiotic for SIBO are prescription treatments. The specific drug, dose, duration, and whether to repeat a course are clinical decisions based on your breath-test pattern and response — this page describes the class and its purpose, not a regimen. Do not self-source or self-dose antibiotics.
How to treat SIBO naturally — diet and herbal antimicrobials
"Natural treatment" for SIBO mostly means two things: diet and herbal antimicrobials. They are not the same kind of tool. Diet changes what reaches your gut bacteria and can make gas, bloating, pain, and bowel swings quieter. Herbal antimicrobials try to suppress microbes pharmacologically, more like antibiotics do — which is why they need the same level of caution.
Diet. A low-FODMAP approach reduces fermentable carbohydrates — short-chain carbs that are poorly absorbed and easily fermented — so there is less substrate for gas and water shifts in the gut. That can ease symptoms while the bigger treatment plan works. In SIBO specifically, low FODMAP is commonly used for symptom control, but much of the stronger diet evidence comes from IBS research, which overlaps with SIBO symptoms rather than proving bacterial eradication. (StatPearls, NCBI Bookshelf) The evidence for symptom relief is solid — «Low FODMAP diet was well tolerated and reduced reported gastrointestinal symptoms, with the greatest effect on reducing bloating» — and, relevant to sequencing, «Those of the patients who were taking antibiotics before the diet were approximately seven times more likely to respond well to the low FODMAP diet (OR = 7.10, p = 0.028)», which supports using diet after antibiotic treatment rather than as a replacement for it (Bogdanowska-Charkiewicz et al., 2026, *Frontiers in Nutrition*). Diet is symptom control, not eradication.
Herbal antimicrobials. Oregano oil, berberine-containing products, and combination herbal protocols are used by some clinicians as an alternative or add-on to antibiotics, but the evidence is much thinner and less standardized than it is for rifaximin. The often-cited herbal-versus-rifaximin study was a small, non-randomized tertiary-practice study: among people who completed follow-up breath testing, 17 of 37 in the herbal group had a negative follow-up lactulose breath test versus 23 of 67 in the rifaximin group; the difference was not statistically significant. In the same study, among rifaximin non-responders offered rescue therapy, 8 of 14 responded after herbal therapy versus 6 of 10 after triple-antibiotic therapy. That is interesting, but it is not proof that DIY herbs "cure" SIBO; it is a signal that needs better prospective trials. (Chedid et al., 2014, *Glob Adv Health Med*) Products also vary in potency, purity, combinations, and labeling, so two bottles with the same marketing language may not behave the same way in your body.
"Natural" is not "harmless": herbal antimicrobials can have real pharmacological effects, side effects, contamination risks, and interactions with prescription or over-the-counter medicines. Use them under clinical supervision, not as a self-assembled DIY protocol, and never in pregnancy, while trying to conceive, or while breastfeeding without medical guidance. The FDA warns that dietary supplements can change how medications are absorbed, metabolized, or cleared, and MotherToBaby notes that many herbal products have not been evaluated for pregnancy or breastfeeding safety. (FDA)
Elemental diet and refractory SIBO
For severe or treatment-resistant SIBO, a clinician may sometimes consider an elemental diet: a liquid formula made from already-broken-down nutrients — typically free amino acids, simple carbohydrates, fats, vitamins, and minerals — that can be absorbed high in the small intestine. The idea is mechanical, not magical: if more of the formula is absorbed early, less fermentable material is left behind for microbes to feed on farther down the gut. (Vasant et al., review, *PMC*)
In the commonly cited SIBO study, people followed an exclusive elemental diet for 14 days, then continued for up to 21 days if the breath test was still abnormal. Among the 93 participants available for analysis, 80% had a normalized lactulose breath test by day 15, and 85% had normalized by day 21. That sounds impressive, but it was not a large modern randomized trial, and "normalized breath test" does not mean a permanent cure. (Pimentel et al., 2004, *Dig Dis Sci*)
This is a high-supervision treatment, not a first-line or DIY option. An exclusive elemental diet can be hard to tolerate, socially restrictive, expensive, and nutritionally demanding; reviews report poor palatability and oral intolerance as major barriers. It can also matter for blood sugar because enteral nutrition formulas deliver concentrated carbohydrate, and people with diabetes, hypoglycemia risk, kidney disease, eating-disorder history, pregnancy, low body weight, or complex medications need clinician-led monitoring. (Vasant et al., review, *PMC*)
When SIBO keeps coming back or does not respond as expected, the next step is usually not "try something stronger forever." It is to ask why the small intestine keeps becoming a place where microbes can overgrow. Refractory cases may prompt repeat breath testing, review of the original test quality, evaluation for methane-dominant intestinal methanogen overgrowth — IMO — and a search for structural or motility drivers such as diverticula, strictures, blind loops, altered anatomy, gastroparesis, diabetes-related dysmotility, connective tissue disease, or other conditions that slow intestinal clearance. (ACG Clinical Guideline: SIBO, 2020)
Preventing recurrence — the part most plans miss
Because SIBO tends to come back when the reason bacteria overgrew in the first place is still there, relapse prevention is not an "extra." It is the part of treatment that makes the rest hold. In one follow-up study, breath-test positivity returned in 12.6% of patients by 3 months, 27.5% by 6 months, and 43.7% by 9 months after successful antibiotic treatment — a useful reminder that killing excess bacteria is different from changing the conditions that let them collect there. (Lauritano et al., 2008, *Am J Gastroenterol*)
The two biggest levers are motility and the underlying cause. Your small intestine is supposed to keep contents moving between meals through coordinated "housekeeping" contractions; when that motion is weak or disrupted, bacteria have more time to linger and re-accumulate. That is why clinicians may use prokinetic medications after treatment in some patients: not as a cure-all, but as a way to support forward movement and help maintain remission. Reviews of SIBO management describe prevention as a layered plan: modify or remove underlying drivers, induce remission with treatment such as antibiotics or an elemental diet when appropriate, then maintain remission with tools such as promotility therapy, dietary modification, and sometimes repeat or cyclical antibiotics under medical supervision. (Grace et al., review, *Aliment Pharmacol Ther*)
The "underlying cause" can be mechanical, neurological, inflammatory, medication-related, or surgery-related. Examples include strictures, diverticula, altered anatomy after abdominal surgery, impaired gut motility, low stomach acid, immune problems, or conditions such as celiac disease, diabetes-related dysmotility, and scleroderma. In practice, this is why the "just take one course of rifaximin" expectation so often disappoints: antibiotics can reduce bacterial load, but they do not automatically fix the terrain. A clinician may need to review your anatomy, medications, bowel pattern, nutritional status, and motility risk factors before deciding what maintenance should look like. (Grace et al., review, *Aliment Pharmacol Ther*)
Lifestyle sits in the supporting layer. It does not replace antibiotics, prescription prokinetics, nutrition therapy, or treatment of structural problems. But it can change how loudly your gut feels what is happening. The gut-brain axis is bidirectional: «chronic stress and anxiety may significantly exacerbate symptoms through the upregulation of cortisol secretion, disrupting the gut microbiome and elevating visceral sensitivity» (Cheung & Kenway, 2026, *Journal of Nutrition and Metabolism*). So when sleep debt, high stress, hard training, irregular meals, constipation, travel, and food reintroduction all stack on top of each other, symptoms may flare even if the medical plan is reasonable.
Welltory does not measure gut bacteria or gases and does not diagnose or treat SIBO. What it can help you do is track the context around your symptoms: sleep, stress load, HRV-based recovery, activity, and how your body responds across treatment and food reintroduction. That pattern can be useful in a clinician-led plan because it helps separate "this food always causes symptoms" from "this food was reintroduced on a week when recovery was low, sleep was short, stress was high, and constipation was building." That is trigger stacking — and seeing it clearly can make relapse prevention feel less random.
How we made it
Made with AI tools, then edited, fact-checked, and medically reviewed by the Welltory team.


Discounts for blog readers: up to 36% off
See what affects your energy, stress, sleep, and daily state with Welltory
This article is for educational purposes only and does not replace medical advice. SIBO treatment — including any antibiotic, herbal antimicrobial, prokinetic, or elemental diet — should be chosen, dosed, and monitored by a clinician. Do not self-prescribe. Beware anyone promising a guaranteed "cure." See a doctor promptly for alarm signs such as unintentional weight loss, blood in stool, severe pain, fever, or persistent diarrhea.
Was this helpful?
Ask AI for a summary of page
Written by Jane Smorodnikova
The founder and CEO of Welltory. A recognized tech leader with two Master's degrees and experience at MIT, she has scaled Welltory to over 17 million users.
Written by Kseniia Iaroslavtseva
Reviewed by Anna Elitzur
With her medical degree, Anna reviews Welltory's health content for medical accuracy and alignment with current clinical guidelines and research.
References
- Melchior C, Hammer H, Bor S, et al. European Consensus on Functional Bloating and Abdominal Distension — An ESNM/UEG Recommendations for Clinical Management (2025), United European Gastroenterology Journal. DOI 10.1002/ueg2.70098. — management list (rifaximin, probiotics, diet, secretagogues); rifaximin as minimally absorbed. https://pmc.ncbi.nlm.nih.gov/articles/PMC12606050/
- Bogdanowska-Charkiewicz D, Górski P, Jurkowska G, et al. Effectiveness of the low FODMAP diet in patients with irritable bowel syndrome and small intestine bacterial overgrowth syndrome (2026), Frontiers in Nutrition. DOI 10.3389/fnut.2026.1725524; PMID 41684777; PMCID PMC12893123. — low FODMAP reduced symptoms, greatest effect on bloating; antibiotics-before-diet ~7× more likely to respond (OR = 7.10, p = 0.028). https://pmc.ncbi.nlm.nih.gov/articles/PMC12893123/
- Cheung SLY, Kenway LC. Pathophysiological Mechanisms and Nonpharmacological Interventions in Irritable Bowel Syndrome: Current Insights and Future Directions (2026), Journal of Nutrition and Metabolism. PMCID PMC12800576; PMID 41541603. — "no known cure for IBS"; gut-brain axis, stress/cortisol, visceral sensitivity. https://pmc.ncbi.nlm.nih.gov/articles/PMC12800576/
- Pimentel M, Saad RJ, Long MD, Rao SSC. ACG Clinical Guideline: Small Intestinal Bacterial Overgrowth (2020), American Journal of Gastroenterology. DOI 10.14309/ajg.0000000000000501; PMID 32023228. — diagnostic and treatment options, antibiotics, methane/IMO framing. https://pubmed.ncbi.nlm.nih.gov/32023228/
- Chedid V, Dhalla S, Clarke JO, et al. Herbal Therapy Is Equivalent to Rifaximin for the Treatment of Small Intestinal Bacterial Overgrowth (2014), Global Advances in Health and Medicine. DOI 10.7453/gahmj.2014.019; PMID 24891990; PMCID PMC4030608. — retrospective; 17/37 (46%) herbal vs 23/67 (34%) rifaximin negative follow-up LBT (P = .24); rescue 8/14 herbal vs 6/10 triple antibiotics. https://pmc.ncbi.nlm.nih.gov/articles/PMC4030608/
- Pimentel M, Constantino T, Kong Y, et al. A 14-Day Elemental Diet Is Highly Effective in Normalizing the Lactulose Breath Test (2004), Digestive Diseases and Sciences. DOI 10.1023/b:ddas.0000011605.43979.e1; PMID 14992438. — 14-day exclusive elemental diet (up to 21 days if still abnormal); of 93, 80% normal LBT by day 15, 85% by day 21. https://pubmed.ncbi.nlm.nih.gov/14992438/
- Lauritano EC, Gabrielli M, Scarpellini E, et al. Small Intestinal Bacterial Overgrowth Recurrence After Antibiotic Therapy (2008), American Journal of Gastroenterology. DOI 10.1111/j.1572-0241.2008.02030.x; PMID 18802998. — recurrence 12.6% (3 mo), 27.5% (6 mo), 43.7% (9 mo) in 80 patients after rifaximin. https://pubmed.ncbi.nlm.nih.gov/18802998/
- Rao SSC, Bhagatwala J. Small Intestinal Bacterial Overgrowth: Clinical Features and Therapeutic Management (2019), Clinical and Translational Gastroenterology. PMCID PMC6884350. — rifaximin, elemental diet, treatment overview. https://pmc.ncbi.nlm.nih.gov/articles/PMC6884350/
- Vasant DH, et al. Elemental diet in refractory / antibiotic-intolerant SIBO and IMO (review), PMC. PMCID PMC11415405. — elemental diet mechanism, indications, tolerability/palatability barriers. https://pmc.ncbi.nlm.nih.gov/articles/PMC11415405/
- Grace E, Shaw C, Whelan K, Andreyev HJN. Review article: small intestinal bacterial overgrowth — prevalence, clinical features, current and developing diagnostic tests, and treatment (review), Aliment Pharmacol Ther. PMID 26780631; PMCID PMC3099351. — layered prevention, motility, prokinetics, underlying drivers. https://pubmed.ncbi.nlm.nih.gov/26780631/
- Mayo Clinic. Small intestinal bacterial overgrowth (SIBO) — Diagnosis & treatment. — treat underlying problem, correct deficiencies, eliminate overgrowth; recurrence after antibiotics. https://www.mayoclinic.org/diseases-conditions/small-intestinal-bacterial-overgrowth/diagnosis-treatment/drc-20370172
- Cleveland Clinic. SIBO (Small Intestinal Bacterial Overgrowth) / Low-FODMAP Diet. — patient-facing treatment framing and low-FODMAP guidance. https://my.clevelandclinic.org/health/diseases/21820-small-intestinal-bacterial-overgrowth-sibo
- Johns Hopkins Medicine. FODMAP Diet: What You Need to Know. — low-FODMAP as part of therapy for IBS, SIBO, and IMO. https://www.hopkinsmedicine.org/health/expert-qa/fodmap-diet-what-you-need-to-know
- FDA. Mixing Medications and Dietary Supplements Can Endanger Your Health. — supplements not pre-approved for safety/effectiveness; can interact with medicines. https://www.fda.gov/consumers/consumer-updates/mixing-medications-and-dietary-supplements-can-endanger-your-health


-2.jpg)


